Schedule 13G ownership disclosure

ZYNERBA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 98986X109

Event date: 2020-11-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,579,161
Percent of class
5.3600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-037198
Form type
SC 13G/A
Filer
ETF MANAGERS GROUP, LLC
CIK
CIK 1645173
Filed
Nov 16, 2020
Reporting period
Nov 13, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub